XHKG
1907
Market cap1.03bUSD
Jul 09, Last price
1.89HKD
1D
0.00%
1Q
-44.57%
IPO
-32.50%
Name
China Risun Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Risun Group Limited, founded in 1995 and headquartered in Beijing, People's Republic of China, is a diversified enterprise focused on the manufacturing, sale, and distribution of coke, coking chemicals, and refined chemicals throughout the PRC and via export. The company structures its operations across four primary divisions: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, and Trading. Its extensive portfolio of chemical products features items like crude benzene, industrial naphthalene phthalic anhydride, coke oven gas methanol, coal-tar pitch, and caprolactam. In addition to its production activities, China Risun provides operation management services to external coke and chemical firms, alongside offering training programs for safety management and operational proficiency. The group also actively trades in coke, coking chemicals, and refined chemical products, and is involved in real estate development initiatives. Its clientele spans critical sectors including iron and steel, non-ferrous metals, coking, and general chemical industries. The company was previously named China Risun Coal Chemicals Group Limited, changing to its current designation in July 2018.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||